AlphaYouSP
Insider selling
Stuart Poulton sold $4K of Karyopharm Therapeutics Inc. (KPTI) stock
Stuart Poulton, EVP, Chief Development Officer of Karyopharm Therapeutics Inc. (KPTI), sold 403 shares of KPTI stock worth $4K, per an SEC Form 4 filed May 15, 2026.
It was an open-market sale.
The trade happened on May 13, 2026, 2 days before it was made public.
KPTI has moved -79.0% since the trade date, from $8.85 to $1.86 (Sep 21, 2026 close).
- Traded
- May 13, 2026
- Disclosed
- May 15, 2026
- Filing delay
- 2 days
- Price since
- -79.0%
- Role
- EVP, Chief Development Officer
- Source
- SEC Form 4
More KPTI insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.